CSMD3 (CUB and Sushi Multiple Domains 3) is a gene that encodes a protein belonging to the CSMD family. This family is characterized by proteins with multiple domains, including CUB (complement C1r/C1s, Uegf, Bmp1) and Sushi (or complement control protein, CCP) domains. The CSMD3 protein is notable for its large size and extensive domain architecture, making it a significant molecule in cell signaling and immune response.The CSMD3 protein is primarily expressed in epithelial tissues and has been implicated in the development and maintenance of these tissues. Its structure, featuring numerous CUB and Sushi domains, suggests a role in cell adhesion and signaling processes. These domains are typically involved in protein-protein interactions and are essential in various biological functions, including complement regulation, embryonic development, and immune responses.
Emerging research has highlighted the role of CSMD3 in various pathological conditions. Notably, alterations in the CSMD3 gene have been associated with certain types of cancer, particularly in epithelial-origin cancers. This association suggests that CSMD3 may play a role in tumorigenesis, possibly through its involvement in cell adhesion and signaling pathways that are crucial in cancer development and progression. Furthermore, CSMD3 has been studied in the context of neurological disorders. Variations in the CSMD3 gene have been linked to neurodevelopmental disorders, indicating its role in brain development and function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
N-Methyl-D-Aspartic acid (NMDA) | 6384-92-5 | sc-200458 sc-200458A | 50 mg 250 mg | $109.00 $369.00 | 2 | |
An agonist for NMDA receptors, potentially influencing synaptic plasticity and neuronal signaling pathways related to GRID2IP. | ||||||
D-Cycloserine | 68-41-7 | sc-221470 sc-221470A sc-221470B sc-221470C | 200 mg 1 g 5 g 25 g | $28.00 $77.00 $142.00 $530.00 | 4 | |
A partial agonist at the glycine site of NMDA receptors, potentially modulating neuronal signaling. | ||||||
(±)-Baclofen | 1134-47-0 | sc-200464 sc-200464A | 1 g 5 g | $56.00 $258.00 | ||
A GABA receptor agonist, potentially modulating neuronal activity and influencing pathways associated with GRID2IP. | ||||||
Nimodipine | 66085-59-4 | sc-201464 sc-201464A | 100 mg 1 g | $61.00 $307.00 | 2 | |
A calcium channel blocker, which can modulate neuronal signaling and potentially impact GRID2IP-associated pathways. | ||||||
Gabapentin | 60142-96-3 | sc-201481 sc-201481A sc-201481B | 20 mg 100 mg 1 g | $53.00 $94.00 $135.00 | 7 | |
Modulates GABAergic signaling and may influence neuronal pathways related to GRID2IP. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Used in neurological research and therapy, potentially affecting neuronal signaling pathways. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
A broad-spectrum anticonvulsant, possibly influencing various neuronal pathways. | ||||||
Memantine hydrochloride | 41100-52-1 | sc-203628 | 50 mg | $69.00 | 4 | |
An NMDA receptor antagonist, used in neurological disorders, potentially affecting neuronal pathways associated with GRID2IP. | ||||||